Sort by
Refine Your Search
-
Listed
-
Field
-
will allow.) The role will be available for 36 months. About you Successful candidates must have a Postdoctoral qualification (PhD), (or be in the process of submitting a PhD) in Immunology or
-
of manufacturing. We have identified an opportunity to combine continuous microfluidic (µF) process models, process analytical technology (PAT) and machine learning (ML) to achieve a paradigm shift in bioprocess
-
biomarker collection and MRI imaging. Both the EJS ACT-PD Trial and Initiative are led by Professor Camille Carroll (Newcastle University, Co-Chief investigator) and Professor Thomas Foltynie (UCL, Co-Chief
-
Foltynie (UCL, Co-Chief investigator). The trial delivery will be overseen by the Medical Research Council Clinical Trials Unit (MRC CTU). This post provides a unique opportunity to develop a practical
-
of the post will involve synthesis and manufacture of prototype viral vectors, as well as testing their ability to treat experimental disease models, in vivo and in vitro. Other The advert will close on 05
-
the application process, please contact Biosciences staffing at . About you You must have a PhD (or be studying towards it) in Medical Physics or Bioengineering, Computational Neuroscience, Applied
-
,USA and Europe nationals. You will be part of a world-leading team in correlative in situ imaging of advanced manufacturing processes, with strong links to synchrotron facilities and industrial